Open access
Aug 2026
Dynamics of in vivo immune remodeling in Ph+ all patients receiving frontline ponatinib and blinatumomab therapy
The present study characterized more in depth the longitudinal immune effects of pona+blina through an integrated peripheral blood (PB) and bone marrow (BM) and integrated peripheral blood (PB) and bone marrow (BM) focus on lymphocyte subset kinetics, phenotypic maturation, and functional competence at different treatm...
N. Peragine, Michela Ansuinelli, G. Radice et al.
· Blood Cancer Journal · 0 citations